Published: 9 January 2017
Authors: Professor Lutz Beckert
This Educational Series provides detailed insight into disease-background and disease-management issues in idiopathic pulmonary fibrosis (IPF), a devastating disorder for which no cure is currently available. However, exciting new treatments and possible combination schedules are emerging with the potential to slow disease progression and/or reduce mortality, thereby substantially shifting the management paradigm for IPF. Several such treatments are discussed in this review, which is intended for use by respiratory physicians and specialists.